EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice

Xinqi Chen, Yang Chen, Catherine Stanton iD, Reynolds Paul Ross iD, Jianxin Zhao, Wei Chen, Bo Yang iD

Nutrients · 18.04.2023 · 15 (8) · 1952

DOI: 10.3390/nu15081952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 18.04.2023. Verfasst von Xinqi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214126, China. Hauptthemen laut MEDLINE: Bifidobacterium breve, Psoriasis, Probiotics. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 111 Project, National Natural Science Foundation of China, Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the dose–response effect of Bifidobacterium breve CCFM683 on relieving psoriasis and its underlying patterns. Specifically, the expression of keratin 16, keratin 17, and involucrin were substantially decreased by administration of 109 CFU and 1010 CFU per day. Moreover, interleukin (IL)-17 and TNF-α levels were substantially decreased by 109 and 1010 CFU/day. Furthermore, the gut microbiota in mice treated with 109 or 1010 CFU/day was rebalanced by improving the diversity, regulating microbe interactions, increasing Lachnoclostridium, and decreasing Oscillibacter. Moreover, the concentrations of colonic bile acids were positively correlated with the effectiveness of the strain in relieving psoriasis. The gavage dose should be more than 108.42 CFU/day to improve psoriasis according to the dose–effect curve. In conclusion, CCFM683 supplementation alleviated psoriasis in a dose-dependent manner by recovering microbiota, promoting bile acid production, regulating the FXR/NF-κB pathway, diminishing proinflammatory cytokines, regulating keratinocytes, and maintaining the epidermal barrier function. These results may help guide probiotic product development and clinical trials in psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bifidobacterium brevePsoriasisProbioticsAnimalsMiceKeratinocytesCytokines

Stichwörter der Autor:innen

Bifidobacterium breveFXR/NF-κB pathwaybile acidsdose–response efficacygut microbiotapsoriasis

Substanzen

Cytokines

Autor:innen und Institutionen

  • State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214126, China.
  • School of Food Science and Technology, Jiangnan University, Wuxi 214126, China.
  • International Joint Research Center for Probiotics & Gut Health, Jiangnan University, Wuxi 214126, China.
  • APC Microbiome Ireland, University College Cork, T12 K8AF Cork, Ireland.
  • Teagasc Food Research Centre, Moorepark, Fermoy, P61 C996 Cork, Ireland.
  • National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214126, China.

ORCID-Profile: Catherine Stanton, Reynolds Paul Ross, Bo Yang

Förderung

  • 111 Project
  • National Natural Science Foundation of China
  • Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province

Zitieren

APA

Chen, X., Chen, Y., Stanton, C., Ross, R. P., Zhao, J., Chen, W., & Yang, B. (2023). Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice. Nutrients, 15(8), 1952. https://doi.org/10.3390/nu15081952

Vancouver

Chen X, Chen Y, Stanton C, Ross RP, Zhao J, Chen W, et al. Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice. Nutrients. 2023;15(8):1952. doi:10.3390/nu15081952

BibTeX
@article{Chen2023,
  author = {Chen, Xinqi and Chen, Yang and Stanton, Catherine and Ross, Reynolds Paul and Zhao, Jianxin and Chen, Wei and Yang, Bo},
  title = {Dose–Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {1952},
  doi = {10.3390/nu15081952}
}
Kostenlos starten →